Back to Browse Journals » Breast Cancer: Targets and Therapy » Volume 4

Breast Cancer: Targets and Therapy


Archive: Volume 4, 2012

Implications for breast cancer dormancy in other areas of medicine

Rameshwar P

Breast Cancer: Targets and Therapy 2012, 4:193-195

Published Date: 5 December 2012

Dormancy in breast cancer

Banys M, Hartkopf AD, Krawczyk N, Kaiser T, Meier-Stiegen F, Fehm T, Neubauer H

Breast Cancer: Targets and Therapy 2012, 4:183-191

Published Date: 5 December 2012

Therapeutic reduction mammoplasty in large-breasted women with cancer using superior and superomedial pedicles

Denewer A, Shahatto F, Elnahas W, Farouk O, Roshdy S, Khater A, Hussein O, Teima S, Hafez M, Zidan S, Shams N, Kotb S

Breast Cancer: Targets and Therapy 2012, 4:167-172

Published Date: 25 October 2012

Keeping an open mind: highlights and controversies of the breast cancer stem cell theory

Shah M, Allegrucci C

Breast Cancer: Targets and Therapy 2012, 4:155-166

Published Date: 26 October 2012

Current and emerging quantitative magnetic resonance imaging methods for assessing and predicting the response of breast cancer to neoadjuvant therapy

Abramson RG, Arlinghaus LR, Weis JA, Li X, Dula AN, Chekmenev EY, Smith SA, Miga MI, Abramson VG, Yankeelov TE

Breast Cancer: Targets and Therapy 2012, 4:139-154

Published Date: 11 October 2012

Potential of afatinib in the treatment of patients with HER2-positive breast cancer

Geuna E, Montemurro F, Aglietta M, Valabrega G

Breast Cancer: Targets and Therapy 2012, 4:131-137

Published Date: 27 August 2012

Five-year follow-up of treatment outcomes in patients with early-stage breast cancer and clinically negative axillary nodes treated with no lymph node dissection or axillary clearance

Yamamoto D, Tanaka K, Tsubota Y, Sueoka N, Shoji T, Kuwana K, Kwon AH

Breast Cancer: Targets and Therapy 2012, 4:125-129

Published Date: 27 August 2012

Sonomammographic characteristics of invasive lobular carcinoma

Kombar OR, Fahmy DM, Brown MV, Farouk O, El-Damshety O

Breast Cancer: Targets and Therapy 2012, 4:115-124

Published Date: 30 July 2012

Targeting γ-secretase in breast cancer

Han J, Shen Q

Breast Cancer: Targets and Therapy 2012, 4:83-90

Published Date: 21 June 2012

Decreased risk of breast cancer associated with oral bisphosphonate therapy

Mathew A, Brufsky A

Breast Cancer: Targets and Therapy 2012, 4:75-81

Published Date: 23 May 2012

Role of pertuzumab in the treatment of HER2-positive breast cancer

Hubalek M, Brantner C, Marth C

Breast Cancer: Targets and Therapy 2012, 4:65-73

Published Date: 28 May 2012

New developments in the treatment of HER2-positive breast cancer

Nahta R

Breast Cancer: Targets and Therapy 2012, 4:53-64

Published Date: 7 May 2012

Role of lapatinib alone or in combination in the treatment of HER2-positive breast cancer

Hurvitz SA, Kakkar R

Breast Cancer: Targets and Therapy 2012, 4:35-51

Published Date: 3 April 2012

Retraction

Singhai R

Breast Cancer: Targets and Therapy 2012, 4:33-34

Published Date: 8 March 2012

Psychiatric morbidity among Egyptian breast cancer patients and their partners and its impact on surgical decision-making

El-Hadidy MA, Elnahas W, Hegazy MAF, Hafez MT, Refky B, Abdel Wahab KM

Breast Cancer: Targets and Therapy 2012, 4:25-32

Published Date: 6 March 2012

A triple negative breast cancer: what it is not!

Katakkar SB

Breast Cancer: Targets and Therapy 2012, 4:21-23

Published Date: 24 February 2012

Potential clinical applications of halichondrins in breast cancer and other neoplasms

Ortega V, Cortes J

Breast Cancer: Targets and Therapy 2012, 4:9-19

Published Date: 8 February 2012

Radiotherapy of early breast cancer in scleroderma patients: our experience with four cases and a short review of the literature

Kyrgias G, Theodorou K, Zygogianni A, Tsanadis K, Zervoudis S, Tzitzikas, Koukourakis M

Breast Cancer: Targets and Therapy 2012, 4:3-8

Published Date: 24 January 2012

Corrigendum

Menis J, Twelves C

Breast Cancer: Targets and Therapy 2012, 4:1-2

Published Date: 30 December 2011